FCFábio Ferreira Carlos

Fábio Ferreira Carlos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fábio Ferreira Carlos has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Pedro Viana Baptista

    Associate Laboratory i4HB – Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, 2819-516 Caparica, Portugal

    7 shared publications
  • Bruno Veigas

    Universidade Nova de Lisboa

    4 shared publications
  • Pedro Pedrosa

    UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516, Caparica, Portugal

    4 shared publications
  • Elvira Fortunato

    CENIMAT|i3N, Department of Materials Science, School of Science and Technology, NOVA University Lisbon and CEMOP/UNINOVA, 2829-516 Caparica, Portugal

    2 shared publications
  • Gonçalo Doria

    Human Molecular Genetics Research Centre (CIGMH), Department of Life Sciences, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal

    2 shared publications
  • Orfeu Flores

    STAB VIDA-Investigação e Serviços em Ciências Biológicas, Madan Parque, 2825-182 Caparica, Portugal

    2 shared publications

Latest Publications

  • Identification of adult and juvenileAtherina presbyterCuvier, 1829 in a marine coastal area adjacent to Tagus estuary (NE Atlantic): A molecular tool for an ecological question

    by F. Almada, P. Carpi, F. Carlos, S. M. Francisco, A. M. Faria, R. Lungu, P. Duarte-Coelho, J. Neto, E. J. Gonçalves, J. I. Robalo


  • Open Access

    Gold Nanoparticles for Diagnostics: Advances towards Points of Care

    by Mílton Cordeiro, Fábio Ferreira Carlos, Pedro Pedrosa, António Lopez, Pedro Viana Baptista

    The remarkable physicochemical properties of gold nanoparticles (AuNPs) have prompted developments in the exploration of biomolecular interactions with AuNP-containing systems, in particular for biomedical applications in diagnostics. These systems show great promise in improving sensitivity, ease of operation and portability. Despite this endeavor, most platforms have yet to reach maturity and make their way into clinics or points of care (POC). Here, we present an overview of emerging and available molecular diagnostics using AuNPs for biomedical sensing that are currently being translated to the clinical setting.


  • Gold Nanoparticles for DNA/RNA-Based Diagnostics

    by Ricardo Franco, Pedro Pedrosa, Fábio Ferreira Carlos, Bruno Veigas, Pedro V. Baptista

    The remarkable physicochemical properties of gold nanoparticles (AuNPs) have prompted development in exploring biomolecular interactions with AuNPs-containing systems, pursuing biomedical applications in diagnostics. Among these applications, AuNPs have been remarkably useful for the development of DNA/RNA detection and characterization systems for diagnostics, including systems suitable for point of need. Here, emphasis will be on available molecular detection schemes of relevant pathogens and their molecular characterization, genomic sequences associated with medical conditions (including cancer), mutation and polymorphism identification, and the quantification of gene expression. The remarkable physicochemical properties of gold nanoparticles (AuNPs) have prompted development in exploring biomolecular interactions with AuNPs-containing systems, pursuing biomedical applications in diagnostics. Among these applications, AuNPs have been remarkably useful for the development of DNA/RNA detection and characterization systems for diagnostics, including systems suitable for point of need. Here, emphasis will be on available molecular detection schemes of relevant pathogens and their molecular characterization, genomic sequences associated with medical conditions (including cancer), mutation and polymorphism identification, and the quantification of gene expression.


  • Open Access

    One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care

    by Bruno Veigas, Pedro Pedrosa, Fábio F Carlos, Liliana Mancio-Silva, Ana Rita Grosso, Elvira Fortunato, Maria M Mota, Pedro V Baptista

    Gold nanoparticles have been widely employed for biosensing purposes with remarkable efficacy for DNA detection. Amongst the proposed systems, colorimetric strategies based on the remarkable optical properties have provided for simple yet effective sequence discrimination with potential for molecular diagnostics at point of need. These systems may also been used for parallel detection of several targets to provide additional information on diagnostics of pathogens. For the first time, we demonstrate that a single Au-nanoprobe may provide for detection of two distinct targets (pathogens) allowing colorimetric multi-target detection. We demonstrate this concept by using one single gold-nanoprobe capable to detect members of the Mycobacterium tuberculosis complex and Plasmodium sp., the etiologic agents of tuberculosis and malaria, respectively. Following characterisation, the developed gold-nanoprobe allowed detection of either target in individual samples or in samples containing both DNA species with the same efficacy. Using one single probe via the non-cross-linking colorimetric methodology it is possible to identify multiple targets in one sample in one reaction. This proof-of-concept approach may easily be integrated into sensing platforms allowing for fast and simple multiplexing of Au-nanoprobe based detection at point-of-need.


  • Gold Nanoparticles for DNA/RNA-Based Diagnostics

    by Ricardo Franco, Pedro Pedrosa, Fábio Ferreira Carlos, Bruno Veigas, Pedro V. Baptista


  • Open Access

    Gold nanoparticle-based theranostics: disease diagnostics and treatment using a single nanomaterial

    by Pedro V Baptista, Alexandra R Fernandes, Sara Figueiredo, Raquel Vinhas, Milton Cordeiro, Fábio Ferreira Carlos, Soraia Mendo

    Nanotheranostics takes advantage of nanotechnology-based systems in order to diagnose and treat a specific disease. This approach is particularly relevant for personalized medicine, allowing the detection of a disease at an early stage, to direct a suitable therapy toward the target tissue based on the molecular profile of the altered phenotype, subsequently facilitating disease monitoring and following treatment. A tailored strategy also enables to reduce the off-target effects associated with universal treatments and improve the safety profile of a given treatment. The unique optical properties of gold nanoparticles, their ease of surface modification, and high surface-to-volume ratio have made them central players in this area. By combining imaging, targeting, and therapeutic agents in a single vehicle, these nanoconjugates are (ought to be) an important tool in the clinics. In this review, the multifunctionality of gold nanoparticles as theranostics agents will be highlighted, as well as the requirements before the translation of these nanoplatforms into routine clinical practice.


  • Single nucleotide polymorphism detection using gold nanoprobes and bio‐microfluidic platform with embedded microlenses

    by Iwona Bernacka‐Wojcik, Hugo Águas, Fabio Ferreira Carlos, Paulo Lopes, Pawel Jerzy Wojcik, Mafalda Nascimento Costa, Bruno Veigas, Rui Igreja, Elvira Fortunato, Pedro Viana Baptista, et al.

    The use of microfluidics platforms combined with the optimal optical properties of gold nanoparticles has found plenty of application in molecular biosensing. This paper describes a bio‐microfluidic platform coupled to a non‐cross‐linking colorimetric gold nanoprobe assay to detect a single nucleotide polymorphism associated with increased risk of obesity fat‐mass and obesity‐associated (FTO) rs9939609 (Carlos et al., 2014). The system enabled significant discrimination between positive and negative assays using a target DNA concentration of 5 ng/µL below the limit of detection of the conventionally used microplate reader (i.e., 15 ng/µL) with 10 times lower solution volume (i.e., 3 µL). A set of optimization of our previously reported bio‐microfluidic platform (Bernacka‐Wojcik et al., 2013) resulted in a 160% improvement of colorimetric analysis results. Incorporation of planar microlenses increased 6 times signal‐to‐loss ratio reaching the output optical fiber improving by 34% the colorimetric analysis of gold nanoparticles, while the implementation of an optoelectronic acquisition system yielded increased accuracy and reduced noise. The microfluidic chip was also integrated with a miniature fiber spectrometer to analyze the assays’ colorimetric changes and also the LEDs transmission spectra when illuminating through various solutions. Furthermore, by coupling an optical microscope to a digital camera with a long exposure time (30 s), we could visualise the different scatter intensities of gold nanoparticles within channels following salt addition. These intensities correlate well to the expected difference in aggregation between FTO positive (none to small aggregates) and negative samples (large aggregates). Biotechnol. Bioeng. 2015;112: 1210–1219.


  • Open Access

    Association of FTO and PPARG polymorphisms with obesity in Portuguese women

    by Pedro Viana Baptista, Fábio Ferreira Carlos, Silva Nunes, Orfeu Flores, Miguel Brito, Gonçalo Doria, Luísa Veiga

    Peer reviewed article authored by (Ferreira Carlos F, Silva-Nunes J, Flores O, Brito M, Doria G, Veiga L, Baptista PV). Read article or submit your manuscript for publishing.